✨ Medicine Consents Schedule




27 MARCH 2008

NEW ZEALAND GAZETTE, No. 64

Schedule

Product:
Arabloc
Active Ingredient:
Leflunomide 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 23 March 2008.

Product:
Arabloc
Active Ingredient:
Leflunomide 100mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 23 March 2008.

Product:
Arabloc
Active Ingredient:
Leflunomide 20mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 23 March 2008.

Product:
Arabloc
Active Ingredient:
Leflunomide 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 23 March 2008.

Product:
Arava
Active Ingredient:
Leflunomide 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 23 March 2008.

Product:
Arava
Active Ingredient:
Leflunomide 100mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 23 March 2008.

Product:
Arava
Active Ingredient:
Leflunomide 20mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 23 March 2008.

Product:
Leflunomide Winthrop
Active Ingredient:
Leflunomide 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 18 May 2008.

Product:
Leflunomide Winthrop
Active Ingredient:
Leflunomide 100mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 18 May 2008.

1857



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2008, No 64


Gazette.govt.nz PDF NZ Gazette 2008, No 64





✨ LLM interpretation of page content

πŸ₯ Renewal of Provisional Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
Medicines Act 1981, Provisional Consent, Distribution, New Medicines, Arabloc, Arava, Leflunomide Winthrop, Leflunomide, Film coated tablet, sanofi-aventis new zealand limited, Aventis Intercontinental, Compeigne, France